Sort
21,453 grants matching “tuberculosis”
Molecular Interactions Of Lymphoid Cell Receptors
$755,976David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Analysis of Host-Pathogen Interactions
$755,694Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$755,670Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2017 · OD
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$755,418Kirill Ostanin · Navigen, Inc. · R44 · FY2015 · AR
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$755,151Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2016 · AI
Toxin secretion and trafficking by Mycobacterium tuberculosis
$754,637Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2024 · AI
Toxin secretion and trafficking by Mycobacterium tuberculosis
$754,637Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2025 · AI
Development of therapeutic chemokine-based formulations
$754,563Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages
$754,519Nevan J Krogan · University Of California, San Francisco · R01 · FY2016 · AI
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study
$754,501Nippie Sarita Shah · Emory University · R01 · FY2022 · AI
INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS
$754,349Yeshiva University · R01 · FY2001 · AI
NIH Director's Pioneer Award (RMI)
$754,346Joseph M McCune · University Of California, San Francisco · DP1 · FY2008 · OD
A Novel Point-of-Care Assay for Diagnosing TB from Blood using Exosomes
$754,249Timothy Charles Rodwell · University Of California, San Diego · R56 · FY2022 · AI
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection
$754,111Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2
$754,096Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2023 · AI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
$754,075Courtney C Aldrich · University Of Minnesota · R01 · FY2021 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$754,049Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
VIOLIN 2.0: Vaccine Information and Ontology LInked kNowledgebase
$753,786Yongqun He · University Of Michigan At Ann Arbor · U24 · FY2022 · AI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
$753,536Igor Kramnik · Boston University Medical Campus · R01 · FY2016 · HL
CENTER FOR AIDS RESEARCH(CFAR)
$753,504Jonathan Karn · Case Western Reserve University · P30 · FY2009 · AI
Interruption of maternal-fetal transmission of HIV
$753,476Joseph M McCune · University Of California, San Francisco · R01 · FY2011 · AI
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
$753,352Tony Y. Hu · Tulane University Of Louisiana · R01 · FY2023 · AI
Role of gamma/delta T cells in Vaccine Induced Immunity
$753,335Daniel F. Hoft · Saint Louis University · R01 · FY2019 · AI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus
$752,999Matthew James Magee · Emory University · R01 · FY2021 · AI
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
$752,693Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI